Corrigendum to "BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia-reperfusion" [Int. Immunopharmacol. 119 (2023) 110201].

Int Immunopharmacol

Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong 226001, People's Republic of China; Department of Respiratory Medicine, Affiliated Hospital 2 of Nantong University, Nantong 226001, People's Republic of China; Department of Emergency, Affiliated Hospital 2 of Nantong University, Nantong 226001, People's Republic of China; Nantong Key Laboratory of Molecular Immunology, Affiliated Hospital 2 of Nantong University, Nantong 226001, People's Republic of China. Electronic address:

Published: March 2024

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.intimp.2024.111541	DOI Listing

Publication Analysis

corrigendum "brg1

"brg1 alleviates

alleviates microglial

microglial activation

activation promoting

promoting keap1-nrf2/ho-1

keap1-nrf2/ho-1 signaling

signaling pathway

pathway minimizing

minimizing oxidative

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!